Relationship between airway hyperresponsiveness to mannitol and adenosine rnonophosphate

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 58, Issue 8, 2003, Pages 762-766

  Currie, G P ^a   Haggart, K ^a   Brannan, J D ^b   Lee, D K C ^a   Anderson, S D ^b   Lipworth, Brian J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Adenosine monophosphate; Airway hyperresponsiveness; Mannitol

Indexed keywords

ADENOSINE PHOSPHATE; MANNITOL;

ADULT; AGED; ALLERGIC ASTHMA; ARTICLE; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PRIORITY JOURNAL; SCREENING;

ADENOSINE MONOPHOSPHATE; ADULT; AEROSOLS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MANNITOL; MIDDLE AGED; POWDERS; SPIROMETRY;

EID: 0041670798     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2003.00226.x     Document Type: Article

References (30)

1. VAN SCHOOR J, JOOS GF, PAUWELS RA. Indirect bronchial hyperresponsiveness in asthma: mechanisms, pharmacology and implications for clinical research. Eur Respir J 2000;16:514-533.
2. COCKCROFT DW. How best to measure airway responsiveness. Am J Respir Crit Care Med 2001;163:1514-1515.
3. POLOSA R, RORKE S, HOLGATE ST. Evolving concepts on the value of adenosine hyperresponsiveness in asthma and chronic obstructive pulmonary disease. Thorax 2002;57:649-654.
4. O'CONNOR BJ, RIDGE SM, BARNES PJ, FULLER RW. Greater effect of inhaled budesonide on adenosine 5′-monophosphate-induced than on sodium-metabi-sulfite-induced bronchoconstriction in asthma. Am Rev Respir Dis 1992;146:560-564.
5. WILSON AM, LIPWORTH BJ. Dose-response evaluation of the therapeutic index for inhaled budesonide in patients with mild-to-moderate asthma. Am J Med 2000;108:269-275.
6. VAN DEN BERGE M, MEIJER RJ, KERSTJENS HA, DE REUS DM, KOETER GH, KAUFFMAN HF, POSTMA DS. PC(20) adenosine 5′-rnonophosphate is more closely associated with airway inflammation in asthma than PC(20) methacholine. Am J Respir Crit Care Med 2001;163:1546-1550.
7. ANDERSON SD, BRANNAN J, SPRING J, SPALDING N, RODWELL LT, CHAN K, GONDA I, WALSH A, CLARK AR. A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. Am J Respir Crit Care Med 1997;156:758-765.
8. BRANNAN JD, KOSKELA H, ANDERSON SD, CHEW N. Responsiveness to mannitol in asthmatic subjects with exercise- and hyperventilation-induced asthma. Am J Respir Crit Care Med 1998;158:1120-1126.
9. HOLZER K, ANDERSON SD, CHAN HK, DOUGLASS J. Mannitol as a challenge test to identify exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med 2003;167: 534-537.
10. HURWITZ KM, ARGYROS GJ, ROACH JM, ELIASSON AH, PHILLIPS YY. Interpretation of eucapnic voluntary hyperventilation in the diagnosis of asthma. Chest 1995;108:1240-1245.
11. CURRIE GP, HAGGART K, LEE DKC, FOWLER SJ, WILSON AM, BRANNAN JD, ANDERSON SD, LIPWORTH BJ. Effects of mediator blockade on adenosine monophosphate and mannitol challenges. Clin Exp Allergy, 2003;33:783-788.
12. CRAPO RO, CASABURI R, COATES AL, ENRIGHT PL, HANKINSON JL, IRVIN CG, MACINTYRE NR, MCKAY RT, WANGER JS, ANDERSON SD, COCKCROFT DW, FISH JE, STERK PJ. Guidelines for methacholine and exercise challenge testing - 1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000;161:309-329.
13. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995;152:1107-1136.
14. BLAND JM, ALTMAN DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310.
15. BRANNAN JD, ANDERSON SD, GOMES K, KING GG, CHAN HK, SEALE JP. Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol. Am J Respir Crit Care Med 2001;163:1420-1425.
16. PEACHELL PT, COLUMBO M, KAGEY-SOBOTKA A, LICHTENSTEIN LM, MARONE G. Adenosine potentiates mediator release from human lung mast cells. Am Rev Respir Dis 1988;138:1143-1151.
17. EGGLESTON PA, KAGEY-SOBOTKA A, SCHLEIMER RP, LICHTENSTEIN LM. Interaction between hyperosmolar and IgE-mediated histamine release from basophils and mast cells. Am Rev Respir Dis 1984;130:86-91.
18. BRANNAN JD, ANDERSON SD, FREED R, LEUPPI JD, KOSKELA H, CHAN HK. Nedocromil sodium inhibits responsiveness to inhaled mannitol in asthmatic subjects. Am J Respir Crit Care Med 2000;161:2096-2099.
19. RICHARDS R, PHILLIPS GD, HOLGATE ST. Nedocromil sodium is more potent than sodium cromoglycate against AMP-induced bronchoconstriction in atopic asthmatic subjects. Clin Exp Allergy 1989;19:285-291.
20. LEFF JA, BUSSE WW, PEARLMAN D, BRONSKY EA, KEMP J, HENDELES L, DOCKHORN R, KUNDU S, ZHANG J, SEIDENBERG BC, REISS TF. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med 1998;339:147-152.
21. CRIMI E, BRUSASCO V, BRANCATISANO M, LOSURDO E, CRIMI P. Effect of nedocromil sodium on adenosine- and methacholine-induced bronchospasm in asthma. Clin Allergy 1987;17:135-141.
22. LEUPPI JD, BRANNAN JD, ANDERSON SD. Bronchial provocation tests: the rationale for using inhaled mannitol as a test for airway hyperresponsiveness. Swiss Med Wkly 2002;132:151-158.
23. BOULET LP, TURCOTTE H, BROCHU A. Persistence of airway obstruction and hyperresponsiveness in subjects with asthma remission. Chest 1994;105:1024-1031.
24. VIGNOLA AM, CHANEZ P, CAMPBELL AM, SOUQUES F, LEBEL B, ENANDER I, BOUSQUET J. Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med 1998;157:403-409.
25. HOLZER K, ANDERSON SD, DOUGLASS J. Exercise in elite summer athletes: challenges for diagnosis. J Allergy Clin Immunol 2002;110:374-380.
26. SONT JK, WILLEMS LN, BEL EH, VAN KRIEKEN JH, VANDENBROUCKE JP, STERK PJ. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 1999;159:1043-1051.
27. HUNTER CJ, BRIGHTLING CE, WOLTMANN G, WARDLAW AJ, PAVORD ID. A comparison of the validity of different diagnostic tests in adults with asthma. Chest 2002;121:1051-1057.
28. GOLDSTEIN MF, VEZA BA, DUNSKY EH, DVORIN DJ, BELECANECH GA, HARALABATOS IC. Comparisons of peak diurnal expiratory flow variation, post-bronchodilator FEV(1) responses, and methacholine inhalation challenges in the evaluation of suspected asthma. Chest 2001;119:1001-1010.
29. GREEN RH, BRIGHTLING CE, MCKENNA S, HARGADON B, PARKER D, BRADDING P, WARDLAW AJ, PAVORD ID. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002;360:1715-1721.
30. LEUPPI JD, SALOME CM, JENKINS CR, ANDERSON SD, XUAN W, MARKS GB, KOSKELA H, BRANNAN JD, FREED R, ANDERSSON M, CHAN HK, WOOLCOCK AJ. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med 2001;163:406-412.